FKTN and Congenital muscular dystrophy, Fukuyama type: Although previous studies have suggested that clinical heterogeneity in patients with FCMD can be explained in part by differences in the types of mutations (24), some of which may influence the enzymatic activity of fukutin, the precise mechanism remains unclear.